Perrigo Management

Management criteria checks 2/4

Perrigo's CEO is Murray Kessler, appointed in Oct 2018, has a tenure of 4.5 years. total yearly compensation is $12.97M, comprised of 9.7% salary and 90.3% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth MX$132.57M. The average tenure of the management team and the board of directors is 4.5 years and 5.9 years respectively.

Key information

Murray Kessler

Chief executive officer

US$13.0m

Total compensation

CEO salary percentage	9.7%
CEO tenure	4.5yrs
CEO ownership	0.1%
Management average tenure	4.5yrs
Board average tenure	5.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Murray Kessler's remuneration changed compared to Perrigo's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2022	US$13m	US$1m	-US$131m
Oct 01 2022	n/a	n/a	-US$86m
Jul 02 2022	n/a	n/a	-US$88m
Apr 02 2022	n/a	n/a	-US$135m
Dec 31 2021	US$11m	US$1m	-US$131m
Oct 02 2021	n/a	n/a	-US$215m
Jul 03 2021	n/a	n/a	-US$135m
Apr 03 2021	n/a	n/a	-US$11m
Dec 31 2020	US$11m	US$1m	US$44m
Sep 26 2020	n/a	n/a	US$77m
Jun 27 2020	n/a	n/a	US$143m
Mar 28 2020	n/a	n/a	US$140m
Dec 31 2019	US$11m	US$1m	US$159m
Sep 28 2019	n/a	n/a	US$247m
Jun 29 2019	n/a	n/a	US$87m
Mar 30 2019	n/a	n/a	US$114m
Dec 31 2018	US$5m	US$278k	US$131m

Compensation vs Market: Murray's total compensation ($USD12.97M) is above average for companies of similar size in the MX market ($USD2.75M).

Compensation vs Earnings: Murray's compensation has increased whilst the company is unprofitable.

CEO

Murray Kessler (62 yo)

4.5yrs

Tenure

US$12,974,336

Compensation

Mr. Murray S. Kessler has been the Chief Executive Officer, President and Director of Perrigo Company plc since October 8, 2018. Mr. Kessler has more years of leadership experience in growing consumer prod...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Murray Kessler	CEO, President & Director	4.5yrs	US$12.97m	0.15% $ 132.6m
Eduardo Bezerra	Executive VP & CFO	less than a year	US$3.33m	no data
Kyle Hanson	Executive VP	less than a year	US$2.30m	no data
Svend Andersen	Executive VP & President of Consumer Self-Care International	6.2yrs	US$3.18m	0.059% $ 52.6m
James Dillard	Executive VP & President of Consumer Self-Care Americas	1.5yrs	US$3.18m	0.019% $ 16.6m
Ronald Janish	Chief Transformation Officer and Executive VP of Global Operations & Supply Chain	7.5yrs	no data	0.019% $ 16.6m
Shannon Hukill	Senior Director of Technical Operations	11.6yrs	no data	no data
Thomas Farrington	Chief Information Officer & Executive VP	16.5yrs	no data	0.0021% $ 1.9m
Alison Ives	Executive VP & Chief Scientific Officer	less than a year	no data	0.0057% $ 5.1m
Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications	no data	no data	no data
Mary Reilly-Brest	Director of Global Organizational and Human Resource Development	15.3yrs	no data	no data
Robert Willis	Chief Human Resources Officer & Executive VP	4.1yrs	no data	0.010% $ 9.0m

4.5yrs

Average Tenure

57yo

Average Age

Experienced Management: PRGO N's management team is considered experienced (4.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Murray Kessler	CEO, President & Director	4.5yrs	US$12.97m	0.15% $ 132.6m
Jeffrey Kindler	Independent Director	6.2yrs	US$400.00k	0.011% $ 9.5m
Donal O'Connor	Independent Director	8.4yrs	US$400.00k	0.013% $ 12.0m
Bradley Alford	Independent Director	6.2yrs	US$387.50k	0.020% $ 18.1m
Theodore Samuels	Independent Director	6.3yrs	US$395.50k	0.033% $ 29.8m
Albert Manzone	Independent Director	less than a year	US$266.29k	no data
Orlando Ashford	Independent Chairman of the Board	2.3yrs	US$511.49k	0.0037% $ 3.3m
Geoffrey Parker	Independent Director	6.4yrs	US$387.50k	0.024% $ 21.9m
Erica Mann	Independent Director	4yrs	US$387.50k	0.0066% $ 5.9m
Adriana Karaboutis	Independent Director	5.9yrs	US$391.00k	0.010% $ 9.2m
Katherine Doyle	Independent Director	2.8yrs	US$387.50k	0.0047% $ 4.2m

5.9yrs

Average Tenure

62yo

Average Age

Experienced Board: PRGO N's board of directors are considered experienced (5.9 years average tenure).

Perrigo Management

Management criteria checks 2/4

Key information

Recent management updates

Perrigo Company plc, Annual General Meeting, May 02, 2024

Perrigo Company plc Announces Erica L. Mann Not to Stand for Re-Election to its Board of Directors

Perrigo Company plc Announces Executive Changes

Perrigo Company plc Appoints Patrick Lockwood-Taylor as Its New Chief Executive Officer

Theodore R. Samuels Not to Stand for Re-Election to the Perrigo Company plc's Board of Directors

Perrigo Company plc Appoints Albert A. Manzone to Serve as A Member of the Board of Directors and Member of the Talent & Compensation Committee, to Be Effective July 30, 2022

Recent updates

Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024

Esteve Healthcare S.L. agreed to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc (NYSE:PRGO) for approximately €280 million.

Perrigo Company plc to Report Q1, 2024 Results on May 07, 2024

Perrigo Company plc, Annual General Meeting, May 02, 2024

Perrigo Company plc Announces Erica L. Mann Not to Stand for Re-Election to its Board of Directors

Perrigo Company plc Reports Earnings Guidance for the Fiscal Year 2024

Perrigo Company plc Increases its Quarterly Dividend, Payable on March 26, 2024

Perrigo Company plc to Report Q4, 2023 Results on Feb 27, 2024

Perrigo Company plc Updates Earnings Guidance for the Fiscal 2023

Perrigo Company plc to Report Q3, 2023 Results on Nov 07, 2023

Perrigo Company plc Announces Executive Changes

Perrigo Company plc Reaffirms Earnings Guidance for the Fiscal 2023

Perrigo Company plc to Report Q2, 2023 Results on Aug 08, 2023

Perrigo Company plc Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive

Perrigo Company plc Appoints Patrick Lockwood-Taylor as Its New Chief Executive Officer

Perrigo Announces U.S. FDA Approval for Nicotine Coated Mint Lozenge

Perrigo Company plc Announces FDA Approval of Opill®? for Over-The-Counter Use

Perrigo Company plc Reaffirms Sales Guidance for the Fiscal Year 2023

Perrigo Announces Quarterly Dividend, Payable on June 20, 2023

Perrigo Company plc to Report Q4, 2022 Results on Feb 27, 2023

Theodore R. Samuels Not to Stand for Re-Election to the Perrigo Company plc's Board of Directors

Upcoming dividend of US$0.26 per share

Perrigo Company plc Provides Earnings Guidance for the Fiscal Year 2022

Perrigo Company plc Announces Quarterly Dividend, Payable on December 20, 2022

Perrigo Company plc (NYSE:PRGO) acquired Good Start Packaging, Inc. from Nestle Canada Inc.

Perrigo Company plc to Report Q3, 2022 Results on Nov 08, 2022

Perrigo Company plc Announces Litigation Update

Perrigo Company Revised Earnings Guidance for the Full Year of 2022

Perrigo Company plc Declares Quarterly Dividend, Payable on September 20, 2022

Perrigo Company plc to Report Q2, 2022 Results on Aug 09, 2022

Perrigo Company plc Appoints Albert A. Manzone to Serve as A Member of the Board of Directors and Member of the Talent & Compensation Committee, to Be Effective July 30, 2022

Perrigo Company plc Promotes Alison Ives to Executive Vice President and Chief Scientific Officer

Perrigo Company plc Announces U.S. FDA Approval for Omeprazole Magnesium Delayed-Release Mini Capsules

Perrigo Company plc Announces Retirement of Todd Kingma as Executive Vice President, General Counsel, and Corporate Secretary, Effective August 31, 2022

Perrigo Company plc Raises Earnings Guidance for the Fiscal Year 2022

Perrigo Company plc Declares Quarterly Dividend, Payable on June 21, 2022

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age